Literature DB >> 19702538

Resveratrol: a natural polyphenol with multiple chemopreventive properties.

Fabrizia Brisdelli1, Gabriele D'Andrea, Argante Bozzi.   

Abstract

Resveratrol, a naturally occurring polyphenol, shows pleiotropic health beneficial effects, including anti-oxidant, anti-inflammatory, anti-aging, cardioprotective and neuroprotective activities. Due to the several protective effects and since this compound is widely distributed in the plant kingdom, resveratrol can be envisaged as a chemo-preventive/curative agent introduced almost daily with the diet. Currently, a number of preclinical findings suggest resveratrol as a promising nature's weapon for cancer prevention and treatment. A remarkable progress in elucidating the molecular mechanisms underlying anti-cancer properties of resveratrol has been achieved in the last years. Concerning the resveratrol mechanism of action as a protective (vs. normal cells and tissues) and toxic (vs. cancer cells) compound, many studies focus on its antioxidant capacity as well as on its ability to trigger and favor the apoptotic cascade in malignant cells. However, a generalized mechanism of action able to explain this dual effect of resveratrol has not yet been clearly established. In addition to these important functions, resveratrol is reported to exhibit several other biological/biochemical protective effects on heart, circulation, brain and age-related diseases which are summarized in this Review.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19702538     DOI: 10.2174/138920009789375423

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  36 in total

1.  Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.

Authors:  W D Johnson; R L Morrissey; A L Usborne; I Kapetanovic; J A Crowell; M Muzzio; D L McCormick
Journal:  Food Chem Toxicol       Date:  2011-09-10       Impact factor: 6.023

2.  Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.

Authors:  Miguel Muzzio; Zhihua Huang; Shu-Chieh Hu; William D Johnson; David L McCormick; Izet M Kapetanovic
Journal:  J Pharm Biomed Anal       Date:  2011-10-25       Impact factor: 3.935

3.  The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitor.

Authors:  Sergiy Kostenko; Mahmud Tareq Hassan Khan; Ingebrigt Sylte; Ugo Moens
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

4.  Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.

Authors:  Wei Li; Jiguang Ma; Qingyong Ma; Bin Li; Liang Han; Jiangbo Liu; Qinhong Xu; Wanxing Duan; Shuo Yu; Fengfei Wang; Erxi Wu
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro.

Authors:  A M Al-Abd; A M Mahmoud; G A El-Sherbiny; M A El-Moselhy; S M Nofal; H A El-Latif; W I El-Eraky; H A El-Shemy
Journal:  Cell Prolif       Date:  2011-10-20       Impact factor: 6.831

6.  Potentiating exercise training with resveratrol.

Authors:  R Ventura-Clapier
Journal:  J Physiol       Date:  2012-07-15       Impact factor: 5.182

Review 7.  Resveratrol--pills to replace a healthy diet?

Authors:  Veronique S Chachay; Carl M J Kirkpatrick; Ingrid J Hickman; Maree Ferguson; Johannes B Prins; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

8.  Chondroprotective effects and mechanisms of resveratrol in advanced glycation end products-stimulated chondrocytes.

Authors:  Feng-Cheng Liu; Li-Feng Hung; Wan-Lin Wu; Deh-Ming Chang; Chuan-Yueh Huang; Jenn-Haung Lai; Ling-Jun Ho
Journal:  Arthritis Res Ther       Date:  2010-09-08       Impact factor: 5.156

9.  Identification of retinoic acid in a high content screen for agents that overcome the anti-myogenic effect of TGF-beta-1.

Authors:  Chateen Krueger; F Michael Hoffmann
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

10.  ELF-MF attenuates quercetin-induced apoptosis in K562 cells through modulating the expression of Bcl-2 family proteins.

Authors:  Fabrizia Brisdelli; Francesca Bennato; Argante Bozzi; Benedetta Cinque; Fabrizio Mancini; Roberto Iorio
Journal:  Mol Cell Biochem       Date:  2014-08-02       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.